158 related articles for article (PubMed ID: 27542221)
21. FOXM1 Deubiquitination by USP21 Regulates Cell Cycle Progression and Paclitaxel Sensitivity in Basal-like Breast Cancer.
Arceci A; Bonacci T; Wang X; Stewart K; Damrauer JS; Hoadley KA; Emanuele MJ
Cell Rep; 2019 Mar; 26(11):3076-3086.e6. PubMed ID: 30865895
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the master regulator FOXM1 in cancer.
Liao GB; Li XZ; Zeng S; Liu C; Yang SM; Yang L; Hu CJ; Bai JY
Cell Commun Signal; 2018 Sep; 16(1):57. PubMed ID: 30208972
[TBL] [Abstract][Full Text] [Related]
23. The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting FOXM1 and FOXM1-interacting factor SMAD3.
Zhang Z; Bu H; Yu J; Chen Y; Pei C; Yu L; Huang X; Tan G; Tan Y
Theranostics; 2019; 9(10):2882-2896. PubMed ID: 31244930
[TBL] [Abstract][Full Text] [Related]
24. PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression.
Wan J; Zhan J; Li S; Ma J; Xu W; Liu C; Xue X; Xie Y; Fang W; Chin YE; Zhang H
Nucleic Acids Res; 2015 Apr; 43(7):3591-604. PubMed ID: 25800736
[TBL] [Abstract][Full Text] [Related]
25. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.
Wan J; Xu W; Zhan J; Ma J; Li X; Xie Y; Wang J; Zhu WG; Luo J; Zhang H
Nucleic Acids Res; 2016 Dec; 44(22):10662-10675. PubMed ID: 27613418
[TBL] [Abstract][Full Text] [Related]
26. BRCA1 function in the intra-S checkpoint is activated by acetylation via a pCAF/SIRT1 axis.
Lahusen TJ; Kim SJ; Miao K; Huang Z; Xu X; Deng CX
Oncogene; 2018 Apr; 37(17):2343-2350. PubMed ID: 29440709
[TBL] [Abstract][Full Text] [Related]
27. PCAF/GCN5-Mediated Acetylation of RPA1 Promotes Nucleotide Excision Repair.
Zhao M; Geng R; Guo X; Yuan R; Zhou X; Zhong Y; Huo Y; Zhou M; Shen Q; Li Y; Zhu W; Wang J
Cell Rep; 2017 Aug; 20(9):1997-2009. PubMed ID: 28854354
[TBL] [Abstract][Full Text] [Related]
28. An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha.
Wilson BJ; Tremblay AM; Deblois G; Sylvain-Drolet G; Giguère V
Mol Endocrinol; 2010 Jul; 24(7):1349-58. PubMed ID: 20484414
[TBL] [Abstract][Full Text] [Related]
29. FOXM1, a typical proliferation-associated transcription factor.
Wierstra I; Alves J
Biol Chem; 2007 Dec; 388(12):1257-74. PubMed ID: 18020943
[TBL] [Abstract][Full Text] [Related]
30. Exogenous pyruvate represses histone gene expression and inhibits cancer cell proliferation via the NAMPT-NAD+-SIRT1 pathway.
Ma R; Wu Y; Zhai Y; Hu B; Ma W; Yang W; Yu Q; Chen Z; Workman JL; Yu X; Li S
Nucleic Acids Res; 2019 Dec; 47(21):11132-11150. PubMed ID: 31598701
[TBL] [Abstract][Full Text] [Related]
31. A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression.
Bi Z; Liu W; Ding R; Wu Y; Dou R; Zhang W; Yuan X; Liu X; Xiong L; Guo Z; Mao C
Eur J Pharmacol; 2017 Feb; 796():175-189. PubMed ID: 28012972
[TBL] [Abstract][Full Text] [Related]
32. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
[TBL] [Abstract][Full Text] [Related]
33. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
[TBL] [Abstract][Full Text] [Related]
34. Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein.
Schimmel J; Eifler K; Sigurðsson JO; Cuijpers SA; Hendriks IA; Verlaan-de Vries M; Kelstrup CD; Francavilla C; Medema RH; Olsen JV; Vertegaal AC
Mol Cell; 2014 Mar; 53(6):1053-66. PubMed ID: 24582501
[TBL] [Abstract][Full Text] [Related]
35. Smad3 is acetylated by p300/CBP to regulate its transactivation activity.
Inoue Y; Itoh Y; Abe K; Okamoto T; Daitoku H; Fukamizu A; Onozaki K; Hayashi H
Oncogene; 2007 Jan; 26(4):500-8. PubMed ID: 16862174
[TBL] [Abstract][Full Text] [Related]
36. An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle.
Park HJ; Wang Z; Costa RH; Tyner A; Lau LF; Raychaudhuri P
Oncogene; 2008 Mar; 27(12):1696-704. PubMed ID: 17891172
[TBL] [Abstract][Full Text] [Related]
37. The Forkhead box transcription factor FOXM1 is required for the maintenance of cell proliferation and protection against oxidative stress in human embryonic stem cells.
Kwok CT; Leung MH; Qin J; Qin Y; Wang J; Lee YL; Yao KM
Stem Cell Res; 2016 May; 16(3):651-61. PubMed ID: 27062359
[TBL] [Abstract][Full Text] [Related]
38. Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity.
Han Y; Jeong HM; Jin YH; Kim YJ; Jeong HG; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2009 May; 383(1):88-92. PubMed ID: 19344692
[TBL] [Abstract][Full Text] [Related]
39. FBXO31 protects against genomic instability by capping FOXM1 levels at the G2/M transition.
Jeffery JM; Kalimutho M; Johansson P; Cardenas DG; Kumar R; Khanna KK
Oncogene; 2017 Feb; 36(7):1012-1022. PubMed ID: 27568981
[TBL] [Abstract][Full Text] [Related]
40. Acetylation promotes TyrRS nuclear translocation to prevent oxidative damage.
Cao X; Li C; Xiao S; Tang Y; Huang J; Zhao S; Li X; Li J; Zhang R; Yu W
Proc Natl Acad Sci U S A; 2017 Jan; 114(4):687-692. PubMed ID: 28069943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
